enzastaurin has been researched along with hydralazine in 1 studies
| Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (hydralazine) | Trials (hydralazine) | Recent Studies (post-2010) (hydralazine) |
|---|---|---|---|---|---|
| 188 | 52 | 99 | 4,580 | 364 | 393 |
| Protein | Taxonomy | enzastaurin (IC50) | hydralazine (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 1.265 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.649 | |
| Lactoperoxidase | Bos taurus (cattle) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachir, S; Bedja, D; Caulfield, MJ; Dietz, HC; Doyle, AJ; Doyle, JJ; Ehsan, H; Habashi, JP; Huso, D; Huso, N; Judge, DP; Lindsay, ME; Myers, L; Rusholme, B; Schoenhoff, F; Squires, O; Thomas, CJ; Van Eyk, JE; Whitworth, RE; Wilson, NK | 1 |
1 other study(ies) available for enzastaurin and hydralazine
| Article | Year |
|---|---|
A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome.
Topics: Adult; Animals; Antihypertensive Agents; Calcium Channel Blockers; Child; Child, Preschool; Disease Models, Animal; Humans; Hydralazine; Indoles; Longitudinal Studies; MAP Kinase Signaling System; Marfan Syndrome; Mice, Inbred C57BL; Protein Kinase C beta; Receptor, Angiotensin, Type 1; Survival Analysis; Treatment Outcome | 2015 |